Literature DB >> 10823870

Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events.

G Gerna1, E Percivalle, F Baldanti, S Sozzani, P Lanzarini, E Genini, D Lilleri, M G Revello.   

Abstract

Using a recently developed model for in vitro generation of pp65-positive polymorphonuclear leukocytes (PMNLs), we demonstrated that PMNLs from immunocompetent subjects may harbor both infectious human cytomegalovirus (HCMV) and viral products (pp65, p72, DNA, and immediate-early [IE] and pp67 late mRNAs) as early as 60 min after coculture with human umbilical vein endothelial cells (HUVEC) or human embryonic lung fibroblasts (HELF) infected with a clinical HCMV isolate (VR6110) or other wild-type strains. The number of PMNLs positive for each viral parameter increased with coculture time. Using HELF infected with laboratory-adapted HCMV strains, only very small amounts of viral DNA and IE and late mRNAs were detected in PMNLs. A cellular mRNA, the vascular cell adhesion molecule-1 mRNA, which is abundantly present in both infected and uninfected HUVEC, was detected in much larger amounts in PMNLs cocultured with VR6110-infected cells than in controls. Coculture of PMNLs with VR6110-infected permissive cells in the presence or absence of RNA, protein, and viral DNA synthesis inhibitors showed that only IE genes were transcribed in PMNLs during coculture. Synthesis of IE transcripts in PMNLs was also supported by the finding that only the copy number of IE mRNA (and not the DNA or the pp67 mRNA) per infected PMNL increased markedly with time, and the pp67 to IE mRNA copy number ratio changed from greater than 10 in infected HUVEC to less than 1 in cocultured PMNLs. Fluorescent probe transfer experiments and electron microscopy studies indicated that transfer of infectious virus and viral products from infected cells to PMNLs is likely to be mediated by microfusion events induced by wild-type strains only. In addition, HCMV pp65 and p72 were both shown to localize in the nucleus of the same PMNLs by double immunostaining. Two different mechanisms may explain the virus presence in PMNLs: (i) one major mechanism consists of transitory microfusion events (induced by wild-type strains only) of HUVEC or HELF and PMNLs with transfer of viable virus and biologically active viral material to PMNLs; and (ii) one minor mechanism, i.e., endocytosis, occurs with both wild-type and laboratory strains and leads to the acquisition of very small amounts of viral nucleic acids. In conclusion, HCMV replicates abortively in PMNLs, and wild-type strains and their products (as well as cellular metabolites and fluorescent dyes) are transferred to PMNLs, thus providing evidence for a potential mechanism of HCMV dissemination in vivo.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823870      PMCID: PMC112050          DOI: 10.1128/jvi.74.12.5629-5638.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Expression of the late cytomegalovirus (CMV) pp150 transcript in leukocytes of AIDS patients is associated with a high viral DNA load in leukocytes and presence of CMV DNA in plasma.

Authors:  G Boivin; J Handfield; E Toma; R Lalonde; M G Bergeron
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

2.  Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors.

Authors:  P Stanier; D L Taylor; A D Kitchen; N Wales; Y Tryhorn; A S Tyms
Journal:  BMJ       Date:  1989-10-07

4.  Prolonged human cytomegalovirus viremia following bone marrow transplantation.

Authors:  J A Zaia; S J Forman; M T Gallagher; E Vanderwal-Urbina; K G Blume
Journal:  Transplantation       Date:  1984-03       Impact factor: 4.939

5.  Quantification of human cytomegalovirus viremia by using monoclonal antibodies to different viral proteins.

Authors:  G Gerna; M G Revello; E Percivalle; M Zavattoni; M Parea; M Battaglia
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

6.  Cloning of an alternate form of vascular cell adhesion molecule-1 (VCAM1).

Authors:  C Hession; R Tizard; C Vassallo; S B Schiffer; D Goff; P Moy; G Chi-Rosso; S Luhowskyj; R Lobb; L Osborn
Journal:  J Biol Chem       Date:  1991-04-15       Impact factor: 5.157

7.  Detection of human cytomegalovirus immediate early antigen in leukocytes as a marker of viremia in immunocompromised patients.

Authors:  M G Revello; E Percivalle; M Zavattoni; M Parea; P Grossi; G Gerna
Journal:  J Med Virol       Date:  1989-10       Impact factor: 2.327

8.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells.

Authors:  J Taylor-Wiedeman; J G Sissons; L K Borysiewicz; J H Sinclair
Journal:  J Gen Virol       Date:  1991-09       Impact factor: 3.891

9.  Comparison between viremia and antigenemia for detection of cytomegalovirus in blood.

Authors:  W van der Bij; J Schirm; R Torensma; W J van Son; A M Tegzess; T H The
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

10.  Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia.

Authors:  G Gerna; M G Revello; E Percivalle; F Morini
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

View more
  57 in total

Review 1.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

2.  Specialization for Cell-Free or Cell-to-Cell Spread of BAC-Cloned Human Cytomegalovirus Strains Is Determined by Factors beyond the UL128-131 and RL13 Loci.

Authors:  Eric P Schultz; Jean-Marc Lanchy; Le Zhang Day; Qin Yu; Christopher Peterson; Jessica Preece; Brent J Ryckman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion.

Authors:  Eric R Kinzler; Teresa Compton
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

4.  Genetic control of fusion pore expansion in the epidermis of Caenorhabditis elegans.

Authors:  Tamar Gattegno; Aditya Mittal; Clari Valansi; Ken C Q Nguyen; David H Hall; Leonid V Chernomordik; Benjamin Podbilewicz
Journal:  Mol Biol Cell       Date:  2007-01-17       Impact factor: 4.138

5.  Human cytomegalovirus DNA in plasma and serum specimens of renal transplant recipients is highly fragmented.

Authors:  René Boom; Cees J A Sol; Tim Schuurman; Alex Van Breda; Jan F L Weel; Marcel Beld; Ineke J M Ten Berge; Pauline M E Wertheim-Van Dillen; Menno D De Jong
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

6.  Dissemination of rat cytomegalovirus through infected granulocytes and monocytes in vitro and in vivo.

Authors:  B W A van der Strate; J L Hillebrands; S S Lycklama à Nijeholt; L Beljaars; C A Bruggeman; M J A Van Luyn; J Rozing; T H The; D K F Meijer; G Molema; M C Harmsen
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes.

Authors:  Gabriele Hahn; Maria Grazia Revello; Marco Patrone; Elena Percivalle; Giulia Campanini; Antonella Sarasini; Markus Wagner; Andrea Gallina; Gabriele Milanesi; Ulrich Koszinowski; Fausto Baldanti; Giuseppe Gerna
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex.

Authors:  Annalisa Macagno; Nadia L Bernasconi; Fabrizia Vanzetta; Erica Dander; Antonella Sarasini; Maria Grazia Revello; Giuseppe Gerna; Federica Sallusto; Antonio Lanzavecchia
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

9.  Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine.

Authors:  Daniel C Freed; Qi Tang; Aimin Tang; Fengsheng Li; Xi He; Zhao Huang; Weixu Meng; Lin Xia; Adam C Finnefrock; Eberhard Durr; Amy S Espeseth; Danilo R Casimiro; Ningyan Zhang; John W Shiver; Dai Wang; Zhiqiang An; Tong-Ming Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Differential ligand binding to a human cytomegalovirus chemokine receptor determines cell type-specific motility.

Authors:  Jennifer Vomaske; Ryan M Melnychuk; Patricia P Smith; Joshua Powell; Laurel Hall; Victor DeFilippis; Klaus Früh; Martine Smit; David D Schlaepfer; Jay A Nelson; Daniel N Streblow
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.